I agree that this site is using cookies. You can find further informations here.
X
Jonasch, Eric
327  results:
Search for persons X
?
1

Efficacy, Effectiveness, and Safety of Interventions for Vo..:

Jonasch, Eric ; Balijepalli, Chakrapani ; Yan, Kevin...
Kidney Cancer.  8 (2024)  1 - p. 1-15 , 2024
Link: https://doi.org/10.3233/..
 
?
2

VHL loss reprograms the immune landscape to promote an infl..:

Wolf, Melissa M. ; Madden, Matthew Z. ; Arner, Emily N....
Journal of Clinical Investigation.  134 (2024)  8 - p. , 2024
Link: https://doi.org/10.1172/..
 
?
3

Belzutifan for von Hippel–Lindau Disease: Pancreatic Lesion..:

Else, Tobias ; Jonasch, Eric ; Iliopoulos, Othon...
Clinical Cancer Research.  30 (2024)  9 - p. 1750-1757 , 2024
Link: https://doi.org/10.1158/..
 
?
4

Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Oc..:

Wiley, Henry E. ; Srinivasan, Ramaprasad ; Maranchie, Jodi K....
Ophthalmology.  , 2024
Link: https://doi.org/10.1016/..
 
?
5

Systemic Therapy Options in VHL Disease:

, In: Von Hippel-Lindau Disease,
Jonasch, Eric - p. 187-197 , 2024
Link: https://doi.org/10.1007/..
 
?
6

Phase I LITESPARK-001 study of belzutifan for advanced soli..:

Jonasch, Eric ; Bauer, Todd M. ; Papadopoulos, Kyriakos P....
European Journal of Cancer.  196 (2024)  - p. 113434 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Epidemiology and economic burden of Von Hippel-Lindau Disea..:

Jonasch, Eric ; Song, Yan ; Freimark, Jonathan...
Orphanet Journal of Rare Diseases.  19 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
8

A Phase 1/2, open label dose-escalation and expansion trial..:

Jonasch, Eric ; Hauke, Ralph ; Falchook, Gerald...
The Oncologist.  28 (2023)  Supplement_1 - p. S12-S12 , 2023
Link: https://doi.org/10.1093/..
 
?
9

Epidemiology and Economic Burden of von Hippel-Lindau Disea..:

Jonasch, Eric ; Song, Yan ; Freimark, Jonathan...
Clinical Genitourinary Cancer.  21 (2023)  2 - p. 238-247 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Phase 1b/2 trial of Ipilimumab, Nivolumab, and Ciforadenant..:

Beckermann, Kathryn ; Rini, Brian ; Haas, Naomi..
The Oncologist.  28 (2023)  Supplement_1 - p. S13-S14 , 2023
Link: https://doi.org/10.1093/..
 
?
11

SYST-18 BELZUTIFAN TREATMENT FOR PATIENTS WITH VON HIPPEL-L..:

Narayan, Vivek ; Iliopoulos, Othon ; Iversen, Ane B...
Neuro-Oncology Advances.  5 (2023)  Supplement_3 - p. iii31-iii31 , 2023
Link: https://doi.org/10.1093/..
 
?
12

CTNI-71. BELZUTIFAN FOR VON HIPPEL-LINDAU DISEASE-RELATED C..:

Iliopoulos, Othon ; Iversen, Ane B ; Narayan, Vivek...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v93-v93 , 2023
Link: https://doi.org/10.1093/..
 
?
13

Guidelines for surveillance of patients with von Hippel‐Lin..:

Daniels, Anthony B. ; Tirosh, Amit ; Huntoon, Kristin...
Cancer.  129 (2023)  19 - p. 2927-2940 , 2023
Link: https://doi.org/10.1002/..
 
?
14

The glycoprotein CD147 defines miRNA‐enriched extracellular..:

Ko, Song Yi ; Lee, WonJae ; Weigert, Melanie...
Journal of Extracellular Vesicles.  12 (2023)  4 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
15

Contributors:

, In: Oncologic Imaging : a Multidisciplinary Approach,
Abdalla, Eddie K. ; Ahuja, Jitesh ; Aluja-Jaramillo, Felipe... - p. v-xii , 2023
Link: https://doi.org/10.1016/..
 
1-15